oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Atofab

Out-of-specification results for atomoxetine content and capsule mass uniformity (OOS) detected in reference tests. Potential effects: reduced efficacy of the medicine.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Atofab
Risk Level
High
Manufacturer
G.L. Pharma GmbH z siedzibą w Austrii
Batch Number
F06874
EAN Code
09008732012231
Recall Date
20.09.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use products from the specified batches; check batch number and expiry date; return the product to the pharmacy or distributor; contact a doctor or pharmacist if in doubt.

Actions Taken

Withdrawal from the national market of the specified batches; prohibition of placing on the market; decision enforceable immediately; prior suspension of distribution and initiation of administrative ...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Out-of-specification results for atomoxetine content and capsule mass uniformity (OOS) detected in reference tests. Potential effects: reduced efficacy of the medicine.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: F06874

Related

Other Recalled Products